The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Gallivac IBD S706 NEO Effervescent tablet for use in drinking water for chickens



Boehringer Ingelheim Vetmedica GmbHVPA10454/079/001

Main Information

Trade NameGallivac IBD S706 NEO Effervescent tablet for use in drinking water for chickens
Active SubstancesAvian infectious bursal disease virus, live
Dosage FormEffervescent tablet
Licence HolderBoehringer Ingelheim Vetmedica GmbH
License Holder AddressBinger Strasse 173
55216 Ingelheim am Rhein
Germany
Licence NumberVPA10454/079/001

Group Information

ATC CodeQI01AD09 avian infectious bursal disease virus (gumboro disease)
Therapeutic ClassImmunological - Live Vaccine
SpeciesChickens

Status

License statusAuthorised
Licence Issued08/01/2021
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back